Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience.
Ann Transplant
; 24: 175-184, 2019 Apr 03.
Article
in En
| MEDLINE
| ID: mdl-30940797
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Postoperative Complications
/
Hematopoietic Stem Cell Transplantation
/
Rituximab
/
Lymphoproliferative Disorders
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Transplant
Journal subject:
TRANSPLANTE
Year:
2019
Document type:
Article
Country of publication:
United States